Clinical trial examines efficacy, safety of drug combination for lung cancer – Phys.Org

by lowes1 on October 2, 2013

Clinical trial examines efficacy, safety of drug combination for lung cancer
Phys.Org
Researchers at the University of Cincinnati Cancer Institute are looking for patients with lung cancer whose tumors test positive for the ALK gene to participate in a clinical trial examining the safety and efficacy of an experimental drug named

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: